Call Us Now
 
Facebook-f Instagram Linkedin-in
CONTACT US
LOGIN

Moxifloxacin Dexamethasone Eye Drops in Hyderabad: A Specialized Ophthalmic Combination

Moxifloxacin Dexamethasone Eye Drops for Hyderabad's Ophthalmic Market

Hyderabad has a strong healthcare ecosystem supported by hospitals, ophthalmology centres, specialist practitioners, pharmacies and pharmaceutical distribution networks. Within this environment, specialized ophthalmic products from EyeKare Kilitch require clearly defined formulations, controlled manufacturing and dependable supply. Combination products containing an antibiotic and corticosteroid represent a distinct category that businesses may evaluate according to product documentation and the requirements of their healthcare channels. 

EyeKare Kilitch lists MOXIEYE-D as Moxifloxacin & Dexamethasone Eye Drops. Its official product page specifies Moxifloxacin Hydrochloride IP equivalent to Moxifloxacin 0.5% w/v and Dexamethasone Sodium Phosphate IP equivalent to Dexamethasone Phosphate 0.1% w/v, with Water for Injections IP q.s. For organizations researching Moxifloxacin Dexamethasone Eye Drops in Hyderabad, this provides a clearly identified combination formulation within EyeKare’s ophthalmic portfolio.

Understanding the Moxifloxacin and Dexamethasone Combination

Moxifloxacin is an antibacterial active ingredient, while Dexamethasone is a corticosteroid. Bringing both into one ophthalmic formulation creates a combination product with two distinct pharmacological components. The suitability of such a formulation depends on the clinical condition, prescribing requirements and approved product information. 

For procurement teams, understanding the composition is an important first step. MOXIEYE-D is listed with Moxifloxacin 0.5% w/v and Dexamethasone Phosphate 0.1% w/v. These exact strengths distinguish the product from standalone Moxifloxacin formulations and from other antibiotic-steroid combinations that may use different active ingredients or concentrations.

MOXIEYE-D: EyeKare's Moxifloxacin Dexamethasone Formulation

MOXIEYE-D is listed by EyeKare Kilitch under its ophthalmic product range as Moxifloxacin & Dexamethasone Eye Drops. The product page identifies the formulation as containing Moxifloxacin Hydrochloride equivalent to Moxifloxacin 0.5% w/v and Dexamethasone Sodium Phosphate equivalent to Dexamethasone Phosphate 0.1% w/v. 

The presence of a defined composition helps distributors, hospitals and pharmaceutical businesses assess the product against their procurement specifications. Product strength, dosage form, packaging, regulatory documentation, storage requirements and supply capabilities should be reviewed together when evaluating an ophthalmic combination product. 

Role of Combination Ophthalmic Formulations

Antibiotic-steroid ophthalmic products are designed around two different therapeutic components. Moxifloxacin provides antibacterial activity, while corticosteroid therapy is associated with reducing inflammation. Because corticosteroids can have important ophthalmic precautions, combination products should be used only according to approved indications and professional medical direction. 

For businesses, this makes accurate product positioning particularly important. Marketing and procurement material should reflect the approved product information rather than presenting a combination eye drop as a general-purpose treatment. Clear documentation also helps healthcare professionals and distribution partners understand the formulation being supplied. 

Manufacturing Considerations for Ophthalmic Products

Ophthalmic manufacturing requires careful attention to formulation accuracy, product quality, packaging and contamination control because the dosage form is administered directly to the eye. EyeKare Kilitch describes itself as a specialized ophthalmic division of Kilitch Healthcare India Ltd. and states that it focuses on ophthalmic solutions, sterile injectables and eye-care innovation. 

EyeKare also states that its products are manufactured in-house and describes its manufacturing operations as supported by quality systems, research and development and quality-control expertise. For businesses evaluating a supplier, these factors can be considered alongside product documentation, formulation capabilities, manufacturing capacity and consistency of supply.

Product Evaluation for Hyderabad Buyers

Confirm the Active Ingredients 

The first consideration is the exact composition. MOXIEYE-D contains Moxifloxacin 0.5% w/v and Dexamethasone Phosphate 0.1% w/v according to EyeKare’s official product page. This should be matched with the relevant approved product information before procurement. 

Review the Dosage Form 

MOXIEYE-D is listed as eye drops, making the dosage form and its associated packaging important procurement considerations. Businesses should review container specifications, storage instructions, shelf life and other applicable documentation supplied with the product. 

Assess the Supplier 

A specialist ophthalmic manufacturer can be evaluated through its product portfolio, manufacturing infrastructure, quality systems, technical support and ability to maintain reliable supply. Looking at these factors together can help procurement teams make a more informed supplier assessment. 

EyeKare's Broader Ophthalmic Portfolio

EyeKare’s product catalogue includes multiple ophthalmic categories, including antibiotic, antibiotic plus NSAID, antibiotic plus steroid, anti-glaucoma, lubricants, NSAIDs and other specialized formulations. MOXIEYE-D appears within the antibiotic plus steroid category, alongside other products in the company’s broader eye-care portfolio.

Businesses can review the EyeKare ophthalmic product portfolio to compare MOXIEYE-D with standalone Moxifloxacin products and other ophthalmic formulations. This wider view can be useful when building a product mix for hospitals, clinics, distributors and pharmacy networks. 

Supporting Ophthalmic Procurement in Hyderabad

Hyderabad’s healthcare and pharmaceutical environment creates demand for specialized products across hospitals, clinics, pharmacies and distribution channels. For businesses serving these markets, product selection can benefit from clear specifications and a supplier with focused ophthalmic capabilities. 

A Moxifloxacin and Dexamethasone combination can be evaluated as part of an ophthalmic portfolio when its composition and approved use align with the intended healthcare channel. EyeKare’s listing of MOXIEYE-D provides businesses with a defined product to assess alongside other antibiotic and steroid ophthalmic options. Clear separation between product specifications, clinical positioning and commercial requirements can also help distributors communicate accurately with healthcare partners and maintain consistency across their procurement and product-information processes. 

Why Consider EyeKare Kilitch for Moxifloxacin Dexamethasone?

EyeKare Kilitch offers MOXIEYE-D as a clearly specified Moxifloxacin and Dexamethasone eye-drop formulation. Its stated focus on ophthalmology, broader product range and manufacturing capabilities provide relevant areas for organizations to consider when evaluating a specialized ophthalmic supplier.  

For organizations evaluating MOXIEYE-D Moxifloxacin and Dexamethasone eye drops, the 0.5% w/v Moxifloxacin and 0.1% w/v Dexamethasone Phosphate strengths provide specific product attributes to review. Procurement decisions should be based on approved documentation, professional requirements and applicable regulations. 

Conclusion

Moxifloxacin Dexamethasone is a specialized antibiotic-steroid ophthalmic combination. EyeKare Kilitch lists MOXIEYE-D with Moxifloxacin 0.5% w/v and Dexamethasone Phosphate 0.1% w/v, formulated with Water for Injections IP q.s. 

For businesses searching for Moxifloxacin Dexamethasone Eye Drops in Hyderabad, EyeKare Kilitch offers a clearly identified combination product within its ophthalmology-focused portfolio. Its product specifications and stated manufacturing capabilities provide useful factors for supplier and procurement evaluation. 

Subscribe Our News Letter!

Subscribe to the EyeCare newsletter to receive updates on the latest developments, events and innovations in ophthalmology.

EyeKare Kilitch  is an innovative pharmaceutical company that discovers, develop, manufactures and market a broad range of healthcare products.

Facebook-f Instagram

Useful links

Contact Us

+91-22-6137 2222

info@eyekare.in

902-B, Godrej Coliseum, Behind Everard Nagar, Off. Eastern Express Highway, Nr. Priyadarshani Circle, Sion (E.), Mumbai - 400 022. INDIA.

© Copyright 2024 – EyeKareKilitch

Group of Companies